| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/30/2001 | US6180140 Modified amino acids for drug delivery |
| 01/30/2001 | US6180116 Histidine derivatives, preparation process and uses |
| 01/30/2001 | CA2124458C Technetium-99m labeled peptides for imaging |
| 01/30/2001 | CA2101942C Technetium-99m labeled polypeptides for imaging |
| 01/30/2001 | CA2052013C Tripeptide antithrombotic agents |
| 01/25/2001 | WO2001005772A1 Pyrazinones, compositions containing such compounds |
| 01/25/2001 | WO2000066587A3 Polyamines and their use in therapy |
| 01/25/2001 | WO2000047605A3 Enterocyte growth factors and method for their isolation |
| 01/25/2001 | DE19933861A1 New 2-aminomethyl-4-cyanothiazole, prepared from thioamide and bromopyruvate ester, used as intermediate for serine protease inhibitors, e.g. thrombin inhibitors |
| 01/24/2001 | EP1070727A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 01/24/2001 | EP1070726A1 Aspartyl dipeptide ester derivatives and sweeteners |
| 01/24/2001 | EP1070084A1 PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase) |
| 01/24/2001 | EP1070083A1 Crystalline forms of 1s- 1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9- (1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino 1, 2-a] 1,2] diazepin- 1-carboxamide |
| 01/24/2001 | EP1070060A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 01/24/2001 | EP1069906A1 Conjugates useful in the treatment of prostrate cancer |
| 01/24/2001 | EP0712389B1 Therapeutic compound - fatty acid conjugates |
| 01/24/2001 | EP0694039B1 1,5-benzodiazepine derivatives having cck antagonistic and or agonistic activity |
| 01/24/2001 | CN1281346A Novel fluorescent reporter molecules and their applications, including assays for caspases |
| 01/24/2001 | CN1281340A Mixed crystals comprising Aspartame and Aspartame derivative and process for producing same |
| 01/24/2001 | CN1281339A Sweetener composition |
| 01/24/2001 | CN1281338A Granular sweetener |
| 01/23/2001 | US6177060 Nmr or x-ray lymphography images |
| 01/23/2001 | CA2221767C A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component |
| 01/18/2001 | WO2001003723A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 01/18/2001 | WO2000063234A3 Pyrrolidincarbonylamino cyclic disulfides as vcam-vla4 antagonists |
| 01/18/2001 | WO2000035492A3 Vitronectin receptor antagonist pharmaceuticals |
| 01/18/2001 | WO2000019210A3 Determining the mechanism of beta-amyloid peptide generation |
| 01/18/2001 | CA2377677A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 01/17/2001 | EP1069118A1 Process for producing 4-thiazolylmethyl derivative |
| 01/17/2001 | EP1068295A1 Cell differentiation/proliferation and maintenance factor and uses thereof |
| 01/17/2001 | EP1068218A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 01/17/2001 | EP1067952A1 Methods for treatment and prevention of infections |
| 01/17/2001 | EP1067894A2 Protease inhibitors |
| 01/16/2001 | US6174915 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/16/2001 | US6174887 Amide compounds and use of the same |
| 01/16/2001 | US6174858 Conjugates useful in the treatment of prostate cancer |
| 01/16/2001 | US6174691 Deactivating a preferential tumor glycoprotein or a cell expressing preferential glycoprotein; exposing preferential glycoprotein or cell expressing the preferential glycoprotein to a toxic substance |
| 01/16/2001 | CA2200192C Amidino and guanidino substituted inhibitors of trypsin-like enzymes |
| 01/16/2001 | CA2164707C Technetium-99m labeled peptides for imaging inflammation |
| 01/16/2001 | CA2068324C Metal-peptide compositions and methods for stimulating hair growth |
| 01/11/2001 | WO2001002601A2 Cell-based assay systems for examining hcv ns3 protease activity |
| 01/11/2001 | WO2001002427A1 Streptogramin derivatives, preparation and compositions containing them |
| 01/11/2001 | WO2001002426A1 A substantially crystalline form of melagatran |
| 01/11/2001 | WO2001002424A2 Peptide boronic acid inhibitors of hepatitis c virus protease |
| 01/11/2001 | WO2001002332A2 Process for the preparation of 3,3-dimethylbutanal |
| 01/11/2001 | WO2001002018A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 01/11/2001 | WO2000063233A3 Peptides and the use thereof to control pests |
| 01/11/2001 | WO2000061608A3 Low-molecular inhibitors of complement proteases |
| 01/11/2001 | WO2000052019A3 Crystallization products of neotame and methods for producing same |
| 01/11/2001 | DE19930177A1 Intermolekular assoziierende Verbindungen und diese umfassende Aggregate Inter-molecular compounds and associating this comprehensive aggregates |
| 01/11/2001 | CA2376965A1 Peptide boronic acid inhibitors of hepatitis c virus protease |
| 01/11/2001 | CA2376944A1 A substantially crystalline form of melagatran |
| 01/11/2001 | CA2376698A1 Streptogramin derivatives, preparation and compositions containing them |
| 01/10/2001 | EP1067138A1 Hydroxyproline derivatives |
| 01/10/2001 | EP1067137A2 Granules of alpha-L-aspartyl-L-phenylalnine methyl ester |
| 01/10/2001 | EP1067136A1 New peptide derivatives |
| 01/10/2001 | EP1066316A1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 01/10/2001 | EP1066315A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |
| 01/10/2001 | EP1056722A4 Bisulfate salt of hiv protease inhibitor |
| 01/10/2001 | EP0742791B1 Macrocyclic difluorostatone derivatives useful as antiviral agents |
| 01/10/2001 | CN1279236A Salt as thrombin inhibitor |
| 01/09/2001 | US6172210 Nucleotide sequences which code enzymatic protein associated with phosphatides; for reduction and prevention of fibrin coagulation and vascular thrombosis; for diagnosing coagulation defects |
| 01/09/2001 | US6172101 Treating human immunodeficiency virus infections |
| 01/09/2001 | US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/09/2001 | US6172044 Acylated enol derivative of α-ketoesters and α-ketoamides |
| 01/09/2001 | US6171846 Culturing cells which are blocked in the synthesis of virginimycins; mutating genes in target microorganism and recovering cells with mutated target genes |
| 01/09/2001 | US6171612 Gene therapy |
| 01/09/2001 | US6171578 Glycoprotein iib/iiia receptor-binding benzodiazepine derivatives covalently linked to metal ion chelators. |
| 01/09/2001 | US6171577 Accessible sulfhydryl group; and hexose moiety recognized by a mammalian liver receptor, wherein the hexose moiety is conjugated to the annexin. |
| 01/04/2001 | WO2001001140A1 Epitopes formed by non-covalent association of conjugates |
| 01/04/2001 | WO2001000665A2 Inhibitors of memapsin 2 and use thereof |
| 01/04/2001 | WO2001000663A2 Catalytically active recombinant memapsin and methods of use thereof |
| 01/04/2001 | WO2001000659A1 Benzimidazolone peptidomimetics as thrombin receptor antagonists |
| 01/04/2001 | WO2001000658A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/04/2001 | WO2001000657A2 Novel indole peptidomimetics as thrombin receptor antagonists |
| 01/04/2001 | WO2001000656A2 Novel indazole peptidomimetics as thrombin receptor antagonists |
| 01/04/2001 | WO2001000622A1 Prodrugs of carbamate inhibitors of impdh |
| 01/04/2001 | WO2001000247A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/04/2001 | WO2001000210A1 Reverse-turn mimetics and methods relating thereto |
| 01/04/2001 | WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 01/04/2001 | CA2376859A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/04/2001 | CA2375952A1 Reverse-turn mimetics and methods relating thereto |
| 01/04/2001 | CA2374610A1 Catalytically active recombinant memapsin and methods of use thereof |
| 01/04/2001 | CA2365341A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/03/2001 | EP1064354A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 01/03/2001 | EP1064300A1 Peptide turn mimetics |
| 01/03/2001 | EP1064298A2 Inhibitors of caspases |
| 01/03/2001 | EP1064021A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 01/03/2001 | EP1064010A1 Peptide compositions and formulations and use of same |
| 01/03/2001 | CN1278828A Sweetener salts of N-[N-3,3-dimethylbutyl)-L-&alpha,-aspartyl]-L-phenylalaning 1-methyl ester |
| 01/03/2001 | CN1278827A Acid salts of N-[N-(3,3-dimethylbutyl)-L-alpha, -aspartyl]-L-phenylalanine 1-methyl ester |
| 01/03/2001 | CN1278826A Metal complexes of N-[N-(3,3-dimethylbutyl)-L-alpha, -aspartyl]-L-phenylalanine 1-methyl ester |
| 01/03/2001 | CN1278791A Process for the preparation of azacyclkylalkanoyl pseudotetrapeptides |
| 01/03/2001 | CN1278790A Chemical compound |
| 01/03/2001 | CN1278530A Novel peptide derivative |
| 01/02/2001 | CA2184696C Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives |
| 01/02/2001 | CA2114156C Elucidation and synthesis of selected pentapeptides |
| 01/02/2001 | CA2086918C Biologically active compounds from blue-green algae |
| 12/28/2000 | WO2000078812A1 Method and compounds for inhibiting activity of serine elastases |
| 12/28/2000 | WO2000078794A1 Cysteinyl protease inhibitors |